Effect of Different Stages of Chronic Kidney Disease and Renal Replacement Therapies on Oxidant-Antioxidant Balance in Uremic Patients

Table 1

Characteristics of the study populations.

	CKD 1; 𝑛=28	CKD 2; 𝑛=28	CKD 3; 𝑛=28	CKD 4; 𝑛=18	HD; 𝑛=40	PD; 𝑛=25
Age (years)	37±13	55±11	45±15	46±14	42±11	39±15
Weight (kg)	66±12.74	67±16.12	67±13.96	61±13.87	56.44±11.37	68.22±10.55
BMI (Kg/m^2)	24.07±7.16	25.35±5.63	24.91±3.54	23.63±4.01	23.15±3.02	25.43±3.28
Sex ratio (M/F)	10/18	11/17	10/18	07/11	22/18	06/06
GFR (mL/min)	86.25±23.87	46±6.95	20.31±5.10	10.75±2.56	—	—
Dialysis duration (months)	—	—	—	—	14–109	05–49
Urea (g/L)	0.34±0.15	0.53±0.20	1.05±0.34	1.67±0.82	1.32±0.36	1.04±0.38
Creatinin (mg/L)	10.30±2.89	18.54±5.26	41.75±11.46	70.03±26.15	102.12±29.37	69.36±36.95
Uric acid (g/L)	52.63±11.28	64.10±13.55	80.85±14.11	86.67±20.01	65.55±13.44	68.10±15.62
Total proteins (g/L)	75.17±5.21	74.29±7.52	71.16±11.15	70.86±10.52	69.92±9.60	67.04±7.36
Cholesterol (g/L)	1.68±0.33	1.89±0.29	1.73±0.32	1.74±0.45	2.17±1.58	1.95±0.56
HDL-cholesterol (g/L)	0.53±0.10	0.48±0.09	0.50±0.10	0.44±0.11	0.36±0.11	0.42±0.07
LDL-cholesterol (g/L)	0.93±0.33	1.13±0.22	0.95±0.93	0.94±0.41	1.14±0.51	1.21±0.45
Triglycerides (g/L)	1.17±0.53	1.39±0.55	1.47±0.74	1.30±0.55	1.64±0.90	1.75±0.89
Erythrocytes, ×10^6/𝜇L	4.72±0.70	4.43±0.59	4.03±0.46	3.25±0.50	3.07±0.73	3.68±0.86
Hemoglobin (g/dL)	13.01±1.36	12.28±1.31	11.46±1.53	8.71±1.37	9.55±1.86	10.38±2.44

BMI: body mass index (weight kg/height m²); GFR: glomerular filtration rate. Data are spoken in mean ± SD.